Chlamydia trachomatis detection and the menstrual cycle

Lancet

Volumn 351, Issue 9099, 1998, Pages 341-342

  Horner, Patrick J ^a   Crowley, Tessa ^b   Leece, Jo ^b   Hughes, Anthony ^b   Smith, George Davey ^b   Caul, Owen E ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; LIGASE CHAIN REACTION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0032583918     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78335-5     Document Type: Article

References (5)

1. 1 Stary A. Chlamydia screening: which sample for which technique? Genitourin Med 1997; 73: 99-102.
2. 2 Caul EO, Horner PJ, Leech J, Crowley T, Paul I, Davey Smith G. Population based screening programmes for Chlamydia trachomatis. Lancet 1997; 349: 1070-71.
3. 3 Crowley T, Horner P, Hughes A, Berry J, Paul I, Caul O. Hormonal factors and the laboratory detection of Chlamydia trachomatis in women: implications for screening? Int J STD AIDS 1997; 8: 25-31.
4. 4 Lee HH, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995; 345: 213-16.
5. 5 Jensen IP, Thorsen P, Møller BR. Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis. Lancet 1997; 349: 329-30.